We observed that rh-endostatin was able to significantly decrease the CD11b+Gr-1+ MDSCs frequency in the tumor (3.21±0.19% vs 4.62±0.43%, p = 0.022, Fig. 7A and B). The gene discussed is COL18A1; the disease is neoplasm.